NCT06167460View on ClinicalTrials.gov

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions

Non Small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung CancerStage IV Non-small Cell Lung CancerTyrosine Kinase Inhibitors

Trial Locations (1)

Unknown

RECRUITING

Medical Genetics Institute, Ho Chi Minh City